Timothy Fisher, DPM
Podiatrist · Fort Collins, CONPI 1275623001
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,331 of the $3,725 with a category attached, or 62.6%. 17 manufacturers reported payments, led by Anika Therapeutics, Inc. at 37.0% of the total. Reporting peaked in 2022 at $2,071 and has fallen 90.2% since, to $204 in 2025.
Across 39 payments — averaging $95.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$1K
- Treace Medical Concepts, Inc.$1K
- Trilliant Surgical LLC.$335
- Stryker$296
- AbbVie$45
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$39
- plus $269 from 11 others
What the payments were for
- Travel & lodging$2,33163%
- Food & beverage$1,39337%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 3 | $1,377 |
| Treace Medical Concepts, Inc. | 11 | $1,364 |
| Trilliant Surgical LLC. | 4 | $335 |
| Stryker | 2 | $296 |
| AbbVie | 2 | $45 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $39 |
| Amgen | 2 | $34 |
| Pfizer | 2 | $32 |
| Merck | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Abbott | 2 | $29 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $29 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Smith+Nephew | 1 | $16 |
| Acera Surgical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemiCAP$1,377
- Lapiplasty System$939
- ORTHOLOC 2 LAPIFUSE$164
- Arsenal$163
- Lapiplasty$138
- VARIAX$132
- STAR$132
- MIB$132
- Cellerate$132
How this compares
$3,725 in reported general payments places this provider in the 65th percentile of 70 podiatrist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 17 | $57 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Fort Collins
- Tucker WorthenFort Collins$3K
- Joshua RawaFort Collins$2K
- Daniel HatchGreeley$7.2M
- Jeremy ChristensenCastle Rock$87K
- Amber KavanaghDenver$20K
- Kenneth MorganDenver$20K
- George ConnerColorado Springs$16K
- Andrea BatraDenver$12K
- Kevin BlueParker$11K
- Christopher JetterCortez$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.